Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Celmed acquires NeuroGeneration and NeuroGenomics

Executive Summary

Theratechnologies' newly created subsidiary, Celmed BioSciences (cell therapy), has acquired two California-based companies developing therapeutics for neurodegenerative diseases, NeuroGeneration and NeuroGenomics, for $12mm in Celmed shares.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies